Yüklüyor......

Myelomonocytic leukaemia following cyclophosphamide therapy of rheumatoid disease.

A 69-year-old woman treated for 31 months with daily oral cyclophosphamide for refractory rheumatoid disease developed acute myelomonocytic leukemia 21/2 years after stopping the drug. The possibility of a casual association between the therapy and subsequent leukaemia is supported by the growing ex...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Love, R R, Sowa, J M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 1975
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1006477/
https://ncbi.nlm.nih.gov/pubmed/1062969
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!